secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCW Biologics Inc. (HCWB)
CIK:        0001828673
Form:       8-K
Filed at:   2024-12-23T23:59:59+00:00
Accession:  0000950170-24-139288
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCW Biologics receives Nasdaq delisting notice for failure to meet MVLS minimum of $50M
--------------------------------------------------------------------------------

- Nasdaq notified HCW Biologics on Dec 17, 2024 that its securities are subject to delisting due to MVLS below $50M threshold for 30 consecutive business days.
- Company failed to regain compliance by the Dec 16, 2024 deadline after a 180-day compliance period that began June 20, 2024.
- HCW Biologics plans to timely request a hearing before Nasdaq Hearing Panel, which will stay delisting pending hearing and possible extension.
- Panel may grant up to 180-day extension; no assurance of continued listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828673/000095017024139288/0000950170-24-139288-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828673/000095017024139288/hcwb-20241217.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-139288

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer